The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.
 
Matthew B. Yurgelun
No Relationships to Disclose
 
Chinedu I. Ukaegbu
No Relationships to Disclose
 
C. Sloane Furniss
No Relationships to Disclose
 
Barbara Kenner
No Relationships to Disclose
 
Alison Klein
Consulting or Advisory Role - OptumInsight; OptumInsight; OptumInsight; OptumInsight
 
Andrew M. Lowy
Honoraria - Celgene; Celgene; Celgene; Celgene
Consulting or Advisory Role - Halozyme; Halozyme; Halozyme; Halozyme; Merck; Merck; Merck; Merck; PFizer; PFizer; PFizer; PFizer
Research Funding - Mitsubishi Tanabe Pharma; Mitsubishi Tanabe Pharma; Mitsubishi Tanabe Pharma; Mitsubishi Tanabe Pharma; Syros Pharmaceuticals; Syros Pharmaceuticals; Syros Pharmaceuticals; Syros Pharmaceuticals
Expert Testimony - Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
Other Relationship - Fount Therapeutics; Fount Therapeutics; Fount Therapeutics; Fount Therapeutics
 
Florencia McAllister
Patents, Royalties, Other Intellectual Property - Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst); Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst); Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst); Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst); Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst); Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst); Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst); Pending Patent on Tumor microbial signatures Pending Patent IL17 combinatorial properties (Inst)
 
Maureen E Mork
No Relationships to Disclose
 
Scott H. Nelson
No Relationships to Disclose
 
Alison Robertson
No Relationships to Disclose
 
Jill E. Stopfer
No Relationships to Disclose
 
Meghan Underhill
No Relationships to Disclose
 
Allyson J. Ocean
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Tyme; Tyme; Tyme; Tyme
Speakers' Bureau - Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo
 
Lisa Madlensky
Employment - Janssen (I); Janssen (I); Janssen (I); Janssen (I)
Patents, Royalties, Other Intellectual Property - Husband has patents through his employment with Janssen. These are methods patents and not related to any therapeutics. (I); Husband has patents through his employment with Janssen. These are methods patents and not related to any therapeutics. (I); Husband has patents through his employment with Janssen. These are methods patents and not related to any therapeutics. (I); Husband has patents through his employment with Janssen. These are methods patents and not related to any therapeutics. (I)
 
Gloria M. Petersen
No Relationships to Disclose
 
Judy Ellen Garber
Consulting or Advisory Role - Aleta BioTherapeutics (I); Aleta BioTherapeutics (I); Aleta BioTherapeutics (I); Aleta BioTherapeutics (I); GTx (I); GTx (I); GTx (I); GTx (I); H3 Biomedicine (I); H3 Biomedicine (I); H3 Biomedicine (I); H3 Biomedicine (I); Helix BioPharma; Helix BioPharma; Helix BioPharma; Helix BioPharma; Konica Minolta; Konica Minolta; Konica Minolta; Konica Minolta; Kronos Bio (I); Kronos Bio (I); Kronos Bio (I); Kronos Bio (I); Novartis (I); Novartis (I); Novartis (I); Novartis (I)
Research Funding - Ambry Genetics; Ambry Genetics; Ambry Genetics; Ambry Genetics; InVitae; InVitae; InVitae; InVitae; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics; Novartis (I); Novartis (I); Novartis (I); Novartis (I)
Other Relationship - AACR; AACR; AACR; AACR; Adrienne Helis Malvin Medical Research Foundation (I); Adrienne Helis Malvin Medical Research Foundation (I); Adrienne Helis Malvin Medical Research Foundation (I); Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Breast Cancer Research Foundation; Breast Cancer Research Foundation; Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Diana Helis Henry Medical Foundation (I); Diana Helis Henry Medical Foundation (I); Diana Helis Henry Medical Foundation (I); Facing our Risk of Cancer Empowered; Facing our Risk of Cancer Empowered; Facing our Risk of Cancer Empowered; Facing our Risk of Cancer Empowered; James P. Wilmot Foundation (I); James P. Wilmot Foundation (I); James P. Wilmot Foundation (I); James P. Wilmot Foundation (I); Susan G. Komen for the Cure (I); Susan G. Komen for the Cure (I); Susan G. Komen for the Cure (I); Susan G. Komen for the Cure (I)
 
Scott Michael Lippman
No Relationships to Disclose
 
Michael Goggins
Patents, Royalties, Other Intellectual Property - Royalty related to licensing as a codiscoverer of PALB2 as a pancreatic cancer susceptibility gene to Myriad Genetics; Royalty related to licensing as a codiscoverer of PALB2 as a pancreatic cancer susceptibility gene to Myriad Genetics; Royalty related to licensing as a codiscoverer of PALB2 as a pancreatic cancer susceptibility gene to Myriad Genetics; Royalty related to licensing as a codiscoverer of PALB2 as a pancreatic cancer susceptibility gene to Myriad Genetics
 
Anirban Maitra
Honoraria - Celgene; Celgene; Celgene; Celgene
Patents, Royalties, Other Intellectual Property - Royalties from Hangzhou Guangkeande (Cosmos) Biotechnology Company LTD for blood based biomarkers of early pancreatic cancer. I do not own stocks in the company nor do I have any research or grant funding from them.; Royalties from Hangzhou Guangkeande (Cosmos) Biotechnology Company LTD for blood based biomarkers of early pancreatic cancer. I do not own stocks in the company nor do I have any research or grant funding from them.; Royalties from Hangzhou Guangkeande (Cosmos) Biotechnology Company LTD for blood based biomarkers of early pancreatic cancer. I do not own stocks in the company nor do I have any research or grant funding from them.; Royalties from Hangzhou Guangkeande (Cosmos) Biotechnology Company LTD for blood based biomarkers of early pancreatic cancer. I do not own stocks in the company nor do I have any research or grant funding from them.
 
Sapna Syngal
Consulting or Advisory Role - DC Health; DC Health; DC Health; DC Health; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee)
Travel, Accommodations, Expenses - Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics